Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations in Participants With a BMI ≥27.0 kg/m²

NCT07338214 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.

NCT NCT07338214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07338214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations in Participants With a BMI ≥27.0 kg/m²
Lead sponsor
Zealand Pharma
Phase
Phase 1
Overall status
Completed
Start date
December 17, 2025
Completion date
March 31, 2026
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight